Examine how converging healthcare, biotech and digital technology could create a new national hub for health innovation and investment.
Key Takeaways
- Sarah de Lagarde now uses an AI-enabled bionic arm prosthesis that learns movement patterns
- Janus Henderson has expanded capabilities to capture convergence-driven healthcare and biotech investment opportunities
- Regulatory processes and lengthy trials are cited as key bottlenecks for bringing new therapies to market